Apps

56 rights groups urge Congress to drop provision deepening US-Israel military ties — 3dA coalition of 56 civil rights and advocacy groups urged Congress to scrap Section 219 of the 2027 NDAA, warning that deepening US-Israel military technology ties would be dangerous as US public opinion shifts against unconditional support for Israel amid the Gaza war. The debate comes as Netanyahu signaled a move to reduce reliance on US military aid within about a decade and some lawmakers have already attempted to block the aid provision as the 3.8 billion annual assistance nears its 2028 expiry.

Nicole Hardy If Israel wants to reduce reliance on our money within a decade, seems like a good moment to actually renegotiate these terms.

Congress delays federal hemp ban to December 11 amid industry concerns — 5dThe U.S. Congress approved a funding bill delaying most hemp‑related restrictions to December 11, extending the current funding through Dec. 11 and allowing more time to craft federal regulations for hemp cannabinoids. Lawmakers from both parties emphasize regulated, adult‑only access and industry groups urging a framework that protects consumers and preserves legitimate hemp products, including hemp beverages and CBD, during the delay.

Chris Dalton Another can-kicking exercise. Just write the actual regulations already instead of extending deadlines every few months.

Stoke, Biogen report four-year zorevunersen data showing sustained seizure control — 5dAt the European Epilepsy Congress in Athens, Stoke Therapeutics and Biogen presented four-year data from Phase 1/2a open-label extensions showing sustained cognitive and behavioral improvements plus durable seizure reductions for zorevunersen in Dravet syndrome, with results supporting ongoing Phase 3 EMPEROR and an anticipated 2027 readout. Separately, GRIN Therapeutics announced its on-site participation at the congress to discuss progress on GRIN-related neurodevelopmental disorders and potential collaborations, underscoring ongoing activity in epilepsy-focused biotech development.

Sam Okafor Good to see multiple companies like GRIN Therapeutics also active at this congress, feels like real momentum building in the rare epilepsy space.

Video — YouTubeMISTRIAL: MA v. Lindsay Clancy - Day 28 | Accused Killer Mom TrialCOURT TV · 3.4M views · Sep 4, 2026

8:21:43

Trump urges Congress to pass federal film tax incentive after Voight meeting — 6dPresident Trump endorses a federal tax incentive to boost film and television production in the United States, arguing it will create jobs and counter industry flight to Canada and other countries, and he is pushing for bipartisan legislation after meetings with Hollywood ambassador Jon Voight. The push is framed as a bipartisan effort to save the U.S. entertainment sector and revitalize production nationwide.

Priya Raman Jon Voight as a Hollywood ambassador is a wild sentence but if it gets bipartisan support to save studio jobs, fine by me.

Global military systems costly, hard to replaceWorld — 6dMilitary systems are shaped by long timelines, high costs, and political pressures, with emphasis on how software, training, and doctrine affect performance as emerging tech like AI and drones are absorbed into forces and strategy. In Congress, Rep. Jake Auchincloss argued against continuing foreign military financing to Israel as part of a protest over the Iran war, signaling a contingent approach to aid that preserves the U.S.-Israel relationship while reassessing support year by year.

Jeffries unveils Day One agenda as Democratic unity faces test — 3dVirginia’s 2025 elections produced a Democratic trifecta, expanding state control and advancing policies on higher minimum wages, paid sick leave, salary transparency, and cannabis sales, signaling a shift toward a more expansive government role in a once-competitive state. In Congress, Democratic leaders face unity tests as they pursue an ambitious agenda to oversight the current president Trump’s administration and address cost of living, while managing a razor-thin majority and intra-party divisions that could shape the party’s ability to govern.

Marcus Bell Cost of living should be priority number one for whoever's in charge. People don't care about the politics, they care about their grocery bills.

Novartis Phase 3 Pelacarsen Trial Misses Cardiovascular Endpoint — 2dNovartis reported that the Phase III Lp(a)HORIZON trial did not meet its primary endpoint, showing that lowering Lp(a) with pelacarsen reduced levels but did not significantly reduce cardiovascular events in approximately 8,000 patients on guideline-directed therapy; the company said full data will be presented at a future medical congress. Meanwhile, Royalty Pharma outlined its financial stance on the pelacarsen investment, noting the trial’s failure won’t derail its recovery of invested funds and that royalties on Spinraza remain a key part of its portfolio as it pursues its 2030 receipts target, with Ionis royalties potentially reverting after a defined cap. The developments reflect a broader scientific and market reevaluation of Lp(a)-targeted therapies and their commercial prospects.